- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
The Value Of Digital Therapeutics

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
The Value Of Digital Therapeutics
Description: Digital therapeutics, a subset of digital health, are evidence-based, clinically validated software that combine health and technology to prevent, treat, or manage a medical condition. In this discussion, Dr. Madhukar Trivedi and Dr. Albert Mei will introduce the role of digital therapeutics in the current mental health landscape, describe the value that digital therapeutics may bring to patients, providers, payers, and health systems, and explore the regulation and reimbursement pathways in today’s digital health landscape.
Objectives:
- Introduce the role of digital therapeutics in the current mental health landscape (obj 1)
- Describe the value that digital therapeutics may bring to patients, providers, payers, and health systems (obj 2)
- Explore regulation and reimbursement in today’s digital health landscape (obj 3)

Madhukar Trivedi, MD
Director, Center For Depression Research & Clinical Care; Betty Jo Hay Distinguished Chair, Mental Health & Julie K. Hersh Chair, Depression Research & Clinical Care, UT Southwestern Medical Center
More

Albert Mei, PharmD
National Lead for Digital Innovation and Managed Ambulatory Care, Elevance Caremore
More

Anna Basoff, PharmD
Managed Market Liaison
More
Speaker Dr. Madhukar Trivedi is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Speaker Dr. Albert Mei was not compensated for their participation.
Speaker Anna Basoff, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)